Formosa Laboratories, Inc.

TWSE:4746 Stock Report

Market Cap: NT$6.3b

Formosa Laboratories Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Formosa Laboratories.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth15.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Analysis Article • Mar 23

Formosa Laboratories' (TWSE:4746) Strong Earnings Are Of Good Quality

Formosa Laboratories, Inc. ( TWSE:4746 ) just reported healthy earnings but the stock price didn't move much. Our...
Analysis Article • Sep 20

Risks To Shareholder Returns Are Elevated At These Prices For Formosa Laboratories, Inc. (TWSE:4746)

With a price-to-earnings (or "P/E") ratio of 46.7x Formosa Laboratories, Inc. ( TWSE:4746 ) may be sending very bearish...
Analysis Article • May 22

Investors Can Find Comfort In Formosa Laboratories' (TWSE:4746) Earnings Quality

Investors were disappointed with the weak earnings posted by Formosa Laboratories, Inc. ( TWSE:4746 ). Despite the soft...
Analysis Article • Apr 19

Benign Growth For Formosa Laboratories, Inc. (TWSE:4746) Underpins Its Share Price

You may think that with a price-to-sales (or "P/S") ratio of 2.8x Formosa Laboratories, Inc. ( TWSE:4746 ) is a stock...
Analysis Article • Apr 19

Here's Why Formosa Laboratories (TPE:4746) Has A Meaningful Debt Burden

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Mar 16

Does Formosa Laboratories, Inc.'s (TPE:4746) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Formosa Laboratories' (TPE:4746) stock is up by 9.9% over the past three months. However, in this article, we decided...
Analysis Article • Feb 08

What Type Of Returns Would Formosa Laboratories'(TPE:4746) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results...
Analysis Article • Jan 11

Formosa Laboratories (TPE:4746) Is Making Moderate Use Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Dec 13

Formosa Laboratories's (TPE:4746) Earnings Are Growing But Is There More To The Story?

Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Formosa Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TWSE:4746 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20264,7723391141,031N/A
12/31/20254,8514414721,315N/A
9/30/20254,8992416591,299N/A
6/30/20254,769-616411,307N/A
3/31/20254,741374291909N/A
12/31/20244,731157138726N/A
9/30/20244,592393226822N/A
6/30/20244,690256396963N/A
3/31/20244,56355401988N/A
12/31/20234,360126286827N/A
9/30/20234,216270233728N/A
6/30/20234,11187691534N/A
3/31/20233,863785250658N/A
12/31/20223,766409203643N/A
9/30/20223,586-94-72349N/A
6/30/20223,252-970-162315N/A
3/31/20223,241-217-268350N/A
12/31/20213,1421,249-203311N/A
9/30/20213,0641,293-196356N/A
6/30/20213,1891,778-93491N/A
3/31/20213,1491,568-370400N/A
12/31/20203,075400-536475N/A
9/30/20202,987460-809534N/A
6/30/20202,962531-1,103360N/A
3/31/20202,768-122-850489N/A
12/31/20192,76012N/A287N/A
9/30/20192,735188N/A83N/A
6/30/20192,630-108N/A0N/A
3/31/20192,72938N/A-123N/A
12/31/20182,688177N/A-81N/A
9/30/20182,659103N/A66N/A
6/30/20182,600266N/A140N/A
3/31/20182,575358N/A136N/A
12/31/20172,539239N/A395N/A
9/30/20172,651347N/A672N/A
6/30/20172,793404N/A889N/A
3/31/20173,022431N/A1,102N/A
12/31/20163,189483N/A1,110N/A
9/30/20163,280457N/A849N/A
6/30/20163,225474N/A628N/A
3/31/20162,813345N/A404N/A
12/31/20152,597282N/A255N/A
9/30/20152,252231N/A300N/A
6/30/20152,115206N/A286N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4746's forecast earnings growth is above the savings rate (1.3%).

Earnings vs Market: Insufficient data to determine if 4746's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4746's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4746's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 4746's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 4746's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/19 21:05
End of Day Share Price 2026/06/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Formosa Laboratories, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullKGI Securities Co. Ltd.
Hsuan ChenKGI Securities Co. Ltd.
Xiaowei HuangMasterlink Securities Investment Advisory